Section Arrow
Quote
ADVB.NASDAQ
- Advanced Biomed Inc.
Quotes are at least 15-min delayed:2026/03/29 20:57 EDT
Regular Hours
Last
 4.1828
-0.0072 (-0.17%)
Day High 
4.2 
Prev. Close
4.19 
1-M High
5.82 
Volume 
24.78K 
Bid
3.92
Ask
4.25
Day Low
3.79 
Open
3.96 
1-M Low
3.6659 
Market Cap 
5.72M 
Currency 美元 
P/E 1.14 
%Yield -- 
10-SMA 4.49 
20-SMA 4.55 
50-SMA 4.99 
52-W High 80 
52-W Low 3.61 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
3.88/--
Enterprise Value
5.72M
Balance Sheet
Book Value Per Share
6.95
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
DHRDanaher Corp181.52-6.13-3.27%37.31PE
OPKOPKO Health1.12-0.05-4.27%-- 
PSNLPersonalis6.34-0.98-13.39%-- 
BIAFbioAffinity Technologies Inc4-0.74-15.61%-- 
SHCSotera Health Company13.13-0.41-3.03%50.15PE
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.